Mechanisms of nicotinic modulation of glutamatergic neuroplasticity in humans

Cerebral Cortex

Volumn 27, Issue 1, 2017, Pages 544-553

  Di Marcello Valladão Lugon, Marcelo ^a,b   Batsikadze, Giorgi ^b   Fresnoza, Shane ^b   Grundey, Jessica ^b   Kuo, Min Fang ^b   Paulus, Walter ^b   Nakamura Palacios, Ester Miyuki ^a   Nitsche, Michael A ^b,c,d  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Dextromethorphan; Neuroplasticity; Nicotine; Nicotinic receptors; Transcranial direct current stimulation

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; DEXTROMETHORPHAN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINE; NICOTINIC AGENT;

ADULT; ANALYSIS OF VARIANCE; ANTAGONISTS AND INHIBITORS; DOSE RESPONSE; DRUG EFFECTS; FEMALE; HUMAN; MALE; METABOLISM; MOTOR CORTEX; MOTOR EVOKED POTENTIAL; NERVE CELL PLASTICITY; PHYSIOLOGY; TIME FACTOR; TRANSCRANIAL DIRECT CURRENT STIMULATION;

ADULT; ANALYSIS OF VARIANCE; DEXTROMETHORPHAN; DOSE-RESPONSE RELATIONSHIP, DRUG; EVOKED POTENTIALS, MOTOR; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; MALE; MOTOR CORTEX; NEURONAL PLASTICITY; NICOTINE; NICOTINIC AGONISTS; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS; TRANSCRANIAL DIRECT CURRENT STIMULATION;

EID: 85016816757     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhv252     Document Type: Article

References (77)

1. Albuquerque EX, Pereira EFR, Alkondon M, Rogers SW. 2009. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol. 89:73-120.
2. Alkondon M, Albuquerque EX. 2004. The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex. Prog Brain Res. 145:109-120.
3. Alkondon M, Pereira EFR, Barbosa CT, Albuquerque EX. 1997. Neuronal nicotinic acetylcholine receptor activation modulates γ-amino butyric acid release from CA1 neurons of rat hippocampal slices. J Pharmacol Exp Ther. 283:1396-1411.
4. Alkondon M, Pereira EFR, Eisenberg HM, Albuquerque EX. 1999. Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1interneurons in rat hippocampal slices. J Neurosci. 19:2693-2705.
5. Artola A, Singer W. 1987. Long-term potentiation and NMDA receptors in rat visual cortex. Nature. 330:649-652.
6. Barone JA. 1999. Domperidone: a peripherally acting dopamineD2-receptor antagonist. Ann Pharmacother. 33(4):429-440.
7. Batsikadze G, Paulus W, Grundey J, Kuo MF, Nitsche MA. 2014. Effect of the Nicotinic α4β2-receptor partial agonist varenicline on non-invasive brain stimulation-induced neuroplasticity in the human motor cortex. Cereb Cortex. 1:11.
8. Batsikadze G, Paulus W, Kuo MF, Nitsche MA. 2013. Effect of serotonin on paired associative stimulation-induced plasticity in the human motor cortex. Neuropsychopharmacology. 38:2260-2267.
9. Bender R, Lange S. 2001. Adjusting for multiple testing-when and how? J Clin Epidemiol. 54:343-349.
10. Browne CJ, Sharma N, Waters KA, Machaalani R. 2010. The effects of nicotine on the alpha-7 and beta-2 nicotinic acetylcholine receptor subunits in the developing piglet brainstem. Int J Dev Neurosci. 28(1):1-7.
11. Burnashev N. 1998. Calcium permeability of ligand-gated channels. Cell Calcium. 24:325-332.
12. Cincotta M, Giovannelli F, Borgheresi A, Balestrieri F, Toscani L, Zaccara G, Carducci F, Viggiano MP, Rossi S. 2010. Optically tracked neuronavigation increases the stability of hand-held focal coil positioning: evidence from “transcranial” magnetic stimulation-induced electrical field measurements. Brain Stimul. 3:119-123.
13. Dajas-Bailador F, Wonnacott S. 2004. Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci. 25:317-324.
14. Feyerabend C, Ings RMJ, Russel MAN. 1985. Nicotine pharmacokinetics and its application to intake, from smoking. Brit J Clin Phamacol. 19:239.
15. Franklin PH, Murray TF. 1992. High affinity [3H]dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel. Mol Pharmacol. 41:134-146.
16. Fresnoza S, Paulus W, Nitsche MA, Kuo MF. 2014. Nonlinear dose dependent impact of D1 receptor activation on motor cortex plasticity in humans. J Neurosci. 34(7):2744-2753.
17. Fritsch B, Reis J, Martinowich K, Schambra HM, Ji Y, Cohen LG, Lu B. 2010. Direct current stimulation promotes BDNFdependent synaptic plasticity: potential implications for motor learning. Neuron. 66:198-204.
18. Gotti C, Clementi F. 2004. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol. 74(6):363-396.
19. Grundey J, Amu R, Ambrus GG, Batsikadze G, Paulus W, Nitsche MA. 2015. Double dissociation of working memory and attentional processes in smokers and non-smokers with and without nicotine. Psychopharmacology (Berl). 232 (14):2491-2501.
20. Grundey J, Freznosa S, Klinker F, Lang N, Paulus W, Nitsche MA. 2013. Cortical excitability in smoking and not smoking individuals with and without nicotine. Psychopharmacology. 229:653-664.
21. Grundey J, Thirugnanasambandam N, Kaminsky K, Drees A, Skwirba AC, Lang N, Paulus W, Nitsche MA. 2012a. Neuroplasticity in cigarette smokers is altered under withdrawal and partially restituted by nicotine exposition. J Neurosci. 32:4156-4162.
22. Grundey J, Thirugnanasambandam N, Kaminsky K, Drees A, Skwirba AC, Lang N, Paulus W, Nitsche MA. 2012b. Rapid effect of nicotine intake on neuroplasticity in non-smoking humans. Front Pharmacol. 3:186.
23. Guenin E, Armogida M, Riff D. 2014. Pharmacokinetic profile of dextromethorphan hydrobromide in a syrup formulation in children and adolescents. Clin Drug Investig. 34 (9):609-616.
24. Heishman SJ, Taylor RC, Henningfield JE. 1994. Nicotine and smoking: a review of effects on human performance. Exp Clin Psychopharmacol. 2:1-51.
25. Hess G, Aizenman CD, Donoghue JP. 1996. Conditions for the induction of long-term potentiation in layer II/III horizontal connections of the rat motor cortex. J Neurophysiol. 75:1765-1778.
26. Hess G, Jacobs KM, Donoghue JP. 1994. N-methyl-D-aspartate receptor mediated component of field potentials evoked in horizontal pathways of rat motor cortex. Neuroscience. 61:225-235.
27. Huang LT, Sherwood JL, Sun YJ, Lodge D, Wang Y. 2010. Activation of presynaptic alpha7 nicotinic receptors evokes an excitatory response in hippocampal CA3 neurons in anaesthetized rats: an in vivo iontophoretic study. Br J Pharmacol. 159 (3):554-565.
28. Iriki A, Pavlides C, Keller A, Asanuma H. 1989. Long-term potentiation in the motor cortex. Science. 245:1385-1387.
29. Jacobsen LK, Krystal JH, Menci WE, Westerveld M, Frost SJ, Pugh KR. 2005. Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol Psychiatry. 57:56-66.
30. Kirkwood A, Dudek SM, Gold JT, Aizenman CD, Bear MF. 1993. Common forms of synaptic plasticity in the hippocampus and neocortex in vitro. Science. 260:1518-1521.
31. Kumari V, Gray JA, Ffytche DH, Mitterschiffthaler MT, Das M, Zachariah E, Vythelingum GN, Williams SC, Simmons A, Sharma T. 2003. Cognitive effects of nicotine in humans: an fMRI study. Neuroimage. 19:1002-1013.
32. Kuo MF, Grosch J, Fregni F, Paulus W, Nitsche MA. 2007. Focusing effect of acetylcholine on neuroplasticity in the human motor cortex. J Neurosci. 27(52):14442-7.
33. Lester RA, Dani JA. 1994. Time-dependent changes in central nicotinic acetylcholine channel kinetics in outside-out patches. Neuropharmacology. 33:27-34.
34. Levin ED, Bradley A, Addy N, Sigurani N. 2002. Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory. Neuroscience. 109:757-765.
35. Levin ED, Briggs SJ, Christopher NC, Rose JE. 1992. Persistence of chronic nicotine-induced cognitive facilitation. Behav Neural Biol. 58:152-158.
36. Levin ED, McClernon FJ, Rezvani AH. 2006. Nicotinic effects on cognitive function: behavioural characterization, pharmacological specification, and anatomic localization. Psychopharmacology. 184(3-4):523-539.
37. Levin ED, Simon BB. 1998. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology. 138: 217-230.
38. Li X, Rainnie DG, McCarley RW, Greene RW. 1998. Presynaptic nicotinic receptors facilitate monoaminergic transmission. J Neurosci. 18:1904-1912.
39. Liebetanz D, Nitsche MA, Tergau F, Paulus W. 2002. Pharmacological approach to synaptic and membrane mechanisms of DC-induced neuroplasticity in man. Brain. 125:2238-2247.
40. Lisman JE. 2001. Three Ca2+ levels affect plasticity differently: the LTP zone, the LTD zone and no man's land. J Physiol. 532:285.
41. Machaalani R, Kashi PK, Waters KA. 2010. Distribution of nicotinic acetylcholine receptor subunits alpha7 and beta2 in the human brainstem and hippocampal formation. J Chem Neuroanat. 40(3):223-231.
42. Maggi L, Sher E, Cherubini E. 2001. Regulation of GABA release by nicotinic acetylcholine receptors in the neonatal rat hippocampus. J Physiol. 536:89-100.
43. Min SK, Moon IW, Ko RW, Shin HS. 2001. Effects of transdermal nicotine on attention and memory in healthy elderly nonsmokers. Psychopharmacology (Berl). 159(1):83-88.
44. Misonou H, Mohapatra DP, Park EW, Leung V, Zhen D, Misonou K, Anderson AE, Trimmer JS. 2004. Regulation of ion channel localization and phosphorylation by neuronal activity. Nat Neurosci. 7:711-718.
45. Monte-Silva K, Kuo MF, Hessenthaler S, Fresnoza S, Liebetanz D, Paulus W, Nitsche MA. 2013. Induction of late LTP-like plasticity in the human motor cortex by repeated non-invasive brain stimulation. Brain Stimul. 6:424-432.
46. Monte-Silva K, Liebetanz D, Grundey J, Paulus W, Nitsche MA. 2010. Dosage-dependent non-linear effect of L-DOPA on human motor cortex plasticity. J Physiol. 588:3415-3424.
47. Myers CS, Robles O, Kakoyannis AN, Sherr JD, Avila MT, Blaxton TA, Thaker GK. 2004. Nicotine improves delayed recognition in schizophrenic patients. Psychopharmacology (Berl). 174(3):334-340.
48. Netzer R, Pimlin P, Trube G. 1993. Dextromethorphan blocks N-methyl-D-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons. Eur J Pharmacol. 238:209-216.
49. Nitsche MA, Fricke K, Henschke U, Schlitterlau A, Liebetanz D, Lang N, Henning S, Tergau F, Paulus W. 2003b. Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. J Physiol. 553:293-301.
50. Nitsche MA, Jaussi W, Liebetanz D, Lang N, Tergau F, Paulus W. 2004b. Consolidation of human motor cortical neuroplasticity by D-cycloserine. Neuropsychopharmacology. 29:1573-1578.
51. Nitsche MA, Liebetanz D, Schlitterlau A, Henschke U, Fricke K, Frommann K, Lang N, Henning S, Paulus W, Tergau F. 2004a. GABAergic modulation of DC stimulation-induced motor cortex excitability shifts in humans. Eur J Neurosci. 19:2720-2726.
52. Nitsche MA, Müller-Dahlhaus F, Paulus W, Ziemann U. 2012. The pharmacology of neuroplasticity induced by non-invasive brain stimulation: building models for the clinical use of CNS active drugs. J Physiol. 590:4641-4662.
53. Nitsche MA, Nitsche MS, Klein CC, Tergau F, Rothwell JC, Paulus W. 2003a. Level of action of cathodal DC polarisation induced inhibition of the human motor cortex. Clin Neurophysiol. 114:600-604.
54. Nitsche MA, Paulus W. 2000. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol. 527:633-639.
55. Nitsche MA, Paulus W. 2001. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology. 57:1899-1901.
56. Nørregaard J, Tønnesen P, Simonsen K, Sawe U. 1992. Long-term nicotine substitution after application of a 16-h nicotine patch in smoking cessation. Eur J ClinPharmacol. 43:57-60.
57. Oldfield RC. 1971. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 9:97-113.
58. Poltavski DV, Petros T. 2005. Effects of transdermal nicotine on prose memory and attention in smokers and non-smokers. Physiol Behav. 83:833-843.
59. Rioult-Pedotti MS, Friedman D, Donoghue JP. 2000. Learning-induced LTP in neocortex. Science. 290:533-536.
60. Rioult-Pedotti MS, Friedman D, Hess G, Donoghue JP. 1998. Strengthening of horizontal cortical connections following skill learning. Nat Neurosci. 1:230-234.
61. Schadel M, Wu D, Otton SV, Kalow W, Sellers EM. 1995. The pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition. J Clin Psychopharmacol. 15(4):263-269.
62. Schilstrom B, Svensson HM, Svensson TH, Nomikos GG. 1998. Nicotine and food induced dopamine release in the nucleus accumbens of the rat: putative role of alpha7 nicotinic receptors in the ventral tegmental area. Neuroscience. 85:1005-1009.
63. Shaffer CL, Gunduz M, Scialis RJ, Fang AF. 2007. Metabolism and disposition of a selective α7 nicotinic acetylcholine receptor agonist in humans. Drug Metab Dispos. 35:1188-1195.
64. Silvasti M, Karttunen P, Tukiainen H. 1987. Pharmacokinetics of dextromethorphan and dextrorphan: a single dose comparison of three preparations in human volunteers. Int J Clin Pharmacol Ther Toxicol. 9:493-497.
65. Stefan K, Kunesch E, Cohen LG, Benecke R, Classen J. 2000. Induction of plasticity in the human motor cortex by paired associative stimulation. Brain. 123(3):572-584.
66. Summers KL, Kem WR, Giacobini E. 1997. Nicotinic agonist modulation of neurotransmitter levels in the rat fronto parietal cortex. Jpn J Pharmacol. 74:139-146.
67. Swan GE, Lessov-Schlaggar CN. 2007. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev. 17:259-273.
68. Thirugnanasambandam N, Grundey J, Adam K, Drees A, Skwirba AC, Lang N, Paulus W, Nitsche MA. 2011. Nicotinergic impact on focal and non-focal neuroplasticity induced by non-invasive brain stimulation in non-smoking humans. Neuropsychopharmacology. 36:879-886.
69. Tortella FC, Pellicano M, Bowery NG. 1989. Dextromethorphan and neuro modulation: old drug coughs up new activities. Trends PharmacolSci. 10:501-507.
70. White HK, Levin ED. 1999. Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. Psychopharmacology (Berl). 143:158-165.
71. Wilson AL, Langley LK, Monley J, Bauer T, Rottunda S, McFalls E, Kovera C, McCarten JR. 1995. Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety. Pharmacol Biochem Behav. 51:509-514.
72. Wolters A, Sandbrink F, Schlottmann A, Kunesch E, Stefan K, Cohen LG, Benecke R, Classen J. 2003. A temporally asymmetric Hebbian rule governing plasticity in the human motor cortex. J Neurophysiol. 89(5):2339-2345.
73. Wong BY, Coulter DA, Choi DW, Prince DA. 1988. Dextrorphan and dextromethorphan, common antitussives, are antiepileptic and antagonize N-methyl-D-aspartate in brain slices. Neurosci Lett. 85:261-266.
74. Wooltorton JR, Pidoplichko VI, Broide RS, Dani JA. 2003. Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J Neurosci. 23:3176-3185.
75. Zappettini S, Grilli M, Olivero G, Chen J, Padolecchia C, Pittaluga A, Tomé AR, Cunha RA, Marchi M. 2014. Nicotinic α7 receptor activation selectively potentiates the function of NMDA receptors in glutamatergic terminals of the nucleus accumbens. Front Cell Neurosci. 8:332.
76. Ziemann U, Chen R, Cohen LG, Hallett M. 1998. Dextromethorphan decreases the excitability of the human motor cortex. Neurology. 51:1320-1324.
77. Ziemann U, Siebner HR. 2008. Modifying motor learning through gating and homeostatic metaplasticity. Brain Stimul. 1:60-66.